Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Association of cystic fibrosis with abnormalities in fatty acid metabolism.

Freedman SD, Blanco PG, Zaman MM, Shea JC, Ollero M, Hopper IK, Weed DA, Gelrud A, Regan MM, Laposata M, Alvarez JG, O'Sullivan BP.

N Engl J Med. 2004 Feb 5;350(6):560-9.

PMID:
14762183
[PubMed - indexed for MEDLINE]
Free Article
2.

Fatty acid metabolism in cystic fibrosis.

Strandvik B.

N Engl J Med. 2004 Feb 5;350(6):605-7. No abstract available.

PMID:
14762189
[PubMed - indexed for MEDLINE]
3.

Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis.

Jumpsen JA, Brown NE, Thomson AB, Paul Man SF, Goh YK, Ma D, Clandinin MT.

J Cyst Fibros. 2006 May;5(2):77-84. Epub 2006 Feb 28.

PMID:
16507353
[PubMed - indexed for MEDLINE]
Free Article
4.

Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis.

Strandvik B, Gronowitz E, Enlund F, Martinsson T, Wahlström J.

J Pediatr. 2001 Nov;139(5):650-5.

PMID:
11713441
[PubMed - indexed for MEDLINE]
5.

Fatty acid imbalance might lead to novel treatments for CF.

Greener M.

Mol Med Today. 2000 Feb;6(2):47-8. No abstract available.

PMID:
10652475
[PubMed - indexed for MEDLINE]
6.

Airway nitric oxide in patients with cystic fibrosis is associated with pancreatic function, Pseudomonas infection, and polyunsaturated fatty acids.

Keen C, Olin AC, Edentoft A, Gronowitz E, Strandvik B.

Chest. 2007 Jun;131(6):1857-64. Epub 2007 Mar 30.

PMID:
17400678
[PubMed - indexed for MEDLINE]
7.

Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis.

Al-Turkmani MR, Freedman SD, Laposata M.

Prostaglandins Leukot Essent Fatty Acids. 2007 Nov-Dec;77(5-6):309-18. Epub 2007 Nov 26. Review.

PMID:
18036797
[PubMed - indexed for MEDLINE]
8.

Fatty acid metabolism in cystic fibrosis.

Strandvik B.

Prostaglandins Leukot Essent Fatty Acids. 2010 Sep;83(3):121-9. doi: 10.1016/j.plefa.2010.07.002. Epub 2010 Jul 31. Review.

PMID:
20673710
[PubMed - indexed for MEDLINE]
9.

Cell culture models demonstrate that CFTR dysfunction leads to defective fatty acid composition and metabolism.

Andersson C, Al-Turkmani MR, Savaille JE, Alturkmani R, Katrangi W, Cluette-Brown JE, Zaman MM, Laposata M, Freedman SD.

J Lipid Res. 2008 Aug;49(8):1692-700. doi: 10.1194/jlr.M700388-JLR200. Epub 2008 Apr 25.

PMID:
18441018
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis.

Sheth S, Shea JC, Bishop MD, Chopra S, Regan MM, Malmberg E, Walker C, Ricci R, Tsui LC, Durie PR, Zielenski J, Freedman SD.

Hum Genet. 2003 Aug;113(3):286-92. Epub 2003 Jun 3.

PMID:
12783301
[PubMed - indexed for MEDLINE]
11.

No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis.

Werner A, Bongers ME, Bijvelds MJ, de Jonge HR, Verkade HJ.

J Lipid Res. 2004 Dec;45(12):2277-86. Epub 2004 Oct 1.

PMID:
15466369
[PubMed - indexed for MEDLINE]
Free Article
12.

Analysis of cystic fibrosis gener product (CFTR) function in patients with pancreas divisum and recurrent acute pancreatitis.

Gelrud A, Sheth S, Banerjee S, Weed D, Shea J, Chuttani R, Howell DA, Telford JJ, Carr-Locke DL, Regan MM, Ellis L, Durie PR, Freedman SD.

Am J Gastroenterol. 2004 Aug;99(8):1557-62.

PMID:
15307877
[PubMed - indexed for MEDLINE]
13.

Decreased peroxisome proliferator activated receptor alpha is associated with bile duct injury in cystic fibrosis transmembrane conductance regulator-/- mice.

Pall H, Zaman MM, Andersson C, Freedman SD.

J Pediatr Gastroenterol Nutr. 2006 Mar;42(3):275-81.

PMID:
16540796
[PubMed - indexed for MEDLINE]
14.

Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis.

De Vizia B, Raia V, Spano C, Pavlidis C, Coruzzo A, Alessio M.

JPEN J Parenter Enteral Nutr. 2003 Jan-Feb;27(1):52-7.

PMID:
12549599
[PubMed - indexed for MEDLINE]
15.

Cystic fibrosis transmembrane conductance regulator (CFTR) activity in nasal epithelial cells from cystic fibrosis patients with severe genotypes.

Andersson C, Dragomir A, Hjelte L, Roomans GM.

Clin Sci (Lond). 2002 Oct;103(4):417-24.

PMID:
12241542
[PubMed - indexed for MEDLINE]
Free Article
16.

Eicosanoids in cystic fibrosis.

Kida Y.

N Engl J Med. 2004 May 6;350(19):2000-1; author reply 2000-1. No abstract available.

PMID:
15128902
[PubMed - indexed for MEDLINE]
Free Article
17.

Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects.

Henderson WR Jr, Astley SJ, McCready MM, Kushmerick P, Casey S, Becker JW, Ramsey BW.

J Pediatr. 1994 Mar;124(3):400-8.

PMID:
8120709
[PubMed - indexed for MEDLINE]
18.

Induction of colitis in cftr-/- mice results in bile duct injury.

Blanco PG, Zaman MM, Junaidi O, Sheth S, Yantiss RK, Nasser IA, Freedman SD.

Am J Physiol Gastrointest Liver Physiol. 2004 Aug;287(2):G491-6. Epub 2004 Apr 2.

PMID:
15064232
[PubMed - indexed for MEDLINE]
Free Article
19.

Increased tissue arachidonic acid and reduced linoleic acid in a mouse model of cystic fibrosis are reversed by supplemental glycerophospholipids enriched in docosahexaenoic acid.

Mimoun M, Coste TC, Lebacq J, Lebecque P, Wallemacq P, Leal T, Armand M.

J Nutr. 2009 Dec;139(12):2358-64. doi: 10.3945/jn.109.110999. Epub 2009 Oct 14.

PMID:
19828687
[PubMed - indexed for MEDLINE]
Free Article
20.

The deltaF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilization in epithelial cells.

Bhura-Bandali FN, Suh M, Man SF, Clandinin MT.

J Nutr. 2000 Dec;130(12):2870-5.

PMID:
11110839
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk